Prevalensi Nyeri Neuropatik pada Pasien dengan Nyeri Kanker di RSUPN dr Cipto Mangunkusumo dan PKN RS Dharmais

Research output: Contribution to journalArticlepeer-review

Abstract

Introduction: Cancer pain is one of the most common complications in cancer. As much as 30-50% of cancer
patients experienced pain. Cancer pain patients have reported complaints of pain with a neuropathic component. Early
diagnosis of neuropathic cancer pain has a clinical implication for patient management. However, the proportion of
neuropathic cancer pain has not been studied in Indonesian population.
Aim: The study was to get an overview of neuropathic pain prevalence among cancer pain patients in Cipto
Mangunkusumo General Hospital and National Cancer Referral Dharmais Hospital.
Methods: The design of this research was cross-sectional. The study was done in Cipto Mangunkusumo General
Hospital and National Cancer Referral Dharmais Hospital in July-September 2019. The subjects in this research were
adult cancer patients who consulted with the Department of Neurology. The data acquired were patient’s demography,
cancer history, imaging, and pain assessment. PainDETECT questionnaire was employed to assess neuropathic pain. The
data were processed and presented descriptively and analytically.
Results: There were 57 subjects obtained in this research with average age of 45.91. As much as 31.6% subjects had
and pain intensity between subjects with and without neuropathic cancer pain. Radiating pain and subject with metastasis
experienced neuropathic cancer pain more frequently.
Discussion: The prevalence of neuropathic cancer pain in the Indonesian population is 31.6%. Radiating pain and
patients with metastasis cancer tend to experienced neuropathic pain more frequently.
Keywords: Cancer, Indonesia, neuropathic pain, prevalenc
Original languageEnglish
JournalNeurona
Publication statusPublished - 2020

Fingerprint

Dive into the research topics of 'Prevalensi Nyeri Neuropatik pada Pasien dengan Nyeri Kanker di RSUPN dr Cipto Mangunkusumo dan PKN RS Dharmais'. Together they form a unique fingerprint.

Cite this